We show that pharmacological inhibition of SCD1 and Scd1 deficiency doubles peripheral Treg numbers and attenuates disease severity in experimental autoimmune encephalomyelitis (EAE), the most commonly used animal model to study MS. This evidence concerns the gene SCD and myeloid sarcoma.